Literature DB >> 32622012

MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.

Ling Wang1, Wei-Xian Liu1, Xiong-Gao Huang2.   

Abstract

BACKGROUND: Diabetic retinopathy (DR) is a major inducer of blindness and visual impairment. As a critical cause for DR, hyperglycaemia is able to trigger multiple biochemical alterations. MiRNAs, which contain various functions, can effectively regulate blood glucose levels. This research aims to confirm the roles of miRNA-199a-3p in the progression of angiogenesis in an in vitro model of DR.
METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was carried to determine the expression levels of miR-199a-3p and VEGF in both hRMECs and APRE-19 cells. The luciferase reporter assay was used to study the interaction between miR-199a-3p and VEGF. Western blot assay was conducted to examine the expression levels of VEGF and the PI3K/AKT signalling pathway. The cell proliferation capacity was detected via the CCK-8 test. The impact of miR-199a-3p on migration was determined using Transwell and wound healing assays. A Matrigel tube formation assay was employed to determine the vascular formation of hRMECs. Flow cytometry was used to determine cell apoptosis in the presence of LY294002 as a PI3K inhibitor.
RESULTS: Our results showed that high glucose (HG) decreased the relative expression level of miR-199a-3p but increased VEGF expression in hRMECs and APRE-19 cells. MiR-199a-3p inhibitor augmented cell growth, migration and angiogenesis of hRMECs. Moreover, upregulation of miR-199a-3p evidently alleviated the increases in cell proliferation, migration and angiogenesis caused by HG. In addition, the luciferase reporter assay indicated that miR-199a-3p directly targeted VEGF. The overexpression of miR-199a-3p obviously restrained the HG-stimulated PI3K/AKT signalling pathway and angiogenesis, which could be further inhibited by LY294002. Moreover, LY294002 could slightly ameliorate the miR-199a-3p inhibitor-stimulated PI3K/AKT signalling pathway and angiogenesis.
CONCLUSION: MiR-199a-3p upregulation ameliorated HG-stimulated angiogenesis of hRMECs by modulating the PI3K/AKT pathway through inhibiting VEGF. Although retinal neovascularization in vivo has not been studied, these in vitro findings provide more evidence for the role of miR-199a-3p upregulation against HG-induced angiogenesis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Diabetic retinopathy; PI3K/AKT pathway; VEGF; microRNA-199a-3p

Mesh:

Substances:

Year:  2020        PMID: 32622012     DOI: 10.1016/j.yexmp.2020.104488

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  10 in total

Review 1.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

2.  miR-199a-5p Plays a Pivotal Role on Wound Healing via Suppressing VEGFA and ROCK1 in Diabetic Ulcer Foot.

Authors:  Hongshu Wang; Xianyi Wang; Xiaomin Liu; Jinbao Zhou; Qianqian Yang; Binshu Chai; Yimin Chai; Zhongliang Ma; Shengdi Lu
Journal:  Oxid Med Cell Longev       Date:  2022-04-07       Impact factor: 7.310

Review 3.  miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.

Authors:  Xingyu Chang; Guomao Zhu; Zongyan Cai; Yaqi Wang; Rongna Lian; Xulei Tang; Chengxu Ma; Songbo Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-10       Impact factor: 5.555

Review 4.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24

5.  Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1.

Authors:  Wei Deng; Dan Huang; HongWu Xie; LiMin Wang; Qun Shen; RongRong Zeng; YuanLian Huang; JianHua Li; Bo Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 6.  Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy.

Authors:  Si-Ru Niu; Jian-Min Hu; Shu Lin; Yu Hong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

7.  Expression of microRNA-155-5p in patients with refractory diabetic macular edema and its regulatory mechanism.

Authors:  Junwen He; Rui Zhang; Shan Wang; Lu Xie; Chengfeng Yu; Tao Xu; Yanzi Li; Tao Yan
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

8.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

9.  Effects of P4 Antagonist RU486 on VEGF and Its Receptors' Signaling during the In Vivo Transition from the Preovulatory to Periovulatory Phase of Ovarian Follicles.

Authors:  Annunziata Mauro; Paolo Berardinelli; Valentina Russo; Nicola Bernabò; Alessandra Martelli; Delia Nardinocchi; Oriana Di Giacinto; Maura Turriani; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

10.  Transient Hyperglycemia and Hypoxia Induce Memory Effects in AngiomiR Expression Profiles of Feto-Placental Endothelial Cells.

Authors:  Jasmin Strutz; Kathrin Baumann; Elisa Weiss; Ursula Hiden
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.